According to Xenetic Biosciences's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.15332. At the end of 2023 the company had a P/S ratio of 2.09.
Year | P/S ratio | Change |
---|---|---|
2023 | 2.09 | -17.39% |
2022 | 2.53 | -83.04% |
2021 | 14.9 | -63.42% |
2020 | 40.8 | -92.02% |
2019 | 512 | |
2018 | N/A | -100% |
2017 | 2.20 | |
2016 | N/A | |
2015 | N/A | |
2014 | N/A | -100% |
2013 | 40.8 |